← Open Payments lookup

PRINCE PAUL: Open Payments

NPI 1073746012 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$813 in 17 payments from 9 companies in 2025. Trend: 2023 $53 · 2024 $559 · 2025 $813

Food & beverage: $638Education: $175
CompanyPaymentsAmount
Astellas Pharma US Inc5$273
JAZZ PHARMACEUTICALS INC.2$167
SANOFI-AVENTIS U.S. LLC1$102
Janssen Biotech, Inc.3$96
Merck Sharp & Dohme LLC2$69
Takeda Pharmaceuticals U.S.A., Inc.1$33
SOBI, INC1$29
Gamida Cell Inc.1$24
Incyte Corporation1$20

Products named: RYLAZE, REZUROCK, DARZALEX, PREVYMIS, Cresemba, DEFITELIO, LIVTENCITY, Xospata.

Industry payments across TX — which companies pay providers there.